Publicacions en col·laboració amb investigadors/ores de Hospital Universitario Nuestra Señora de Candelaria (128)

2024

  1. Association between occupational exposure and chronic obstructive pulmonary disease and respiratory symptoms in the Spanish population

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 16-22

  2. Associations of serum sclerostin levels with body composition, pulmonary function, and exacerbations in COPD patients

    Pulmonology, Vol. 30, Núm. 6, pp. 512-521

  3. Home noninvasive ventilation in severe COPD: in whom does it work and how?

    ERJ Open Research, Vol. 10, Núm. 1

  4. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

  5. Lung Function and Symptoms of Exposure to the Volcanic Eruption in the Canary Islands: First Follow-Up of the ASHES Study

    Archivos de Bronconeumologia, Vol. 60, Núm. 8, pp. 475-482

  6. Occupational Exposures, Chronic Obstructive Pulmonary Disease and Tomographic Findings in the Spanish Population

    Toxics, Vol. 12, Núm. 10

  7. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2023

  1. Circulating miR-206 and miR-1246 as Markers in the Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

  2. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

  3. Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study

    Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 717-724

2022

  1. ANTES Program: One Year on

    Archivos de Bronconeumologia

  2. Associations between serum mitokine levels and outcomes in stable COPD: an observational prospective study

    Scientific Reports, Vol. 12, Núm. 1

  3. Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort

    Respirology, Vol. 27, Núm. 4, pp. 286-293

  4. Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease

    Respiratory Research, Vol. 23, Núm. 1

  5. Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study

    Respiratory Research, Vol. 23, Núm. 1

  6. Respiratory symptoms and their determinants in the general Spanish population: changes over 20 years

    ERJ Open Research, Vol. 8, Núm. 4

  7. Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update

    Archivos de Bronconeumologia, Vol. 58, Núm. 4, pp. 345-351

  8. Spanish COPD Guidelines (GesEPOC) 2021 Update Diagnosis and Treatment of COPD Exacerbation Syndrome

    Archivos de Bronconeumologia, Vol. 58, Núm. 2, pp. 159-170

  9. Spanish COPD Guidelines (GesEPOC) 2021: Updated Pharmacological treatment of stable COPD

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 69-81

  10. The 7 Cardinal Sins of COPD in Spain

    Archivos de Bronconeumologia